Feed Preview

Cognitive Decline: Environmental And Genetic Factors

Cognitive Decline: Environmental And Genetic Factors diagram by MriMan, Shutterstock
MriMan, Shutterstock

This feed focuses on the role of environmental and genetic factors including environmental policies, disease susceptibility, and socioeconomic status on cognitive decline. Here is the latest research.

Top 20 most recent papers
April 26, 2020

An update on memory formation and retrieval: An engram-centric approach

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Mehmet Bostancıklıoğlu
May 14, 2020

MAPT haplotype-stratified GWAS reveals differential association for AD risk variants

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Samantha L StricklandAlzheimer's Disease Genetics Consortium
April 18, 2020
Review

Early diagnosis of Alzheimer's disease: the role of biomarkers including advanced EEG signal analysis. Report from the IFCN-sponsored panel of experts

Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
P M RossiniB Dubois
April 24, 2020

Contribution of mixed pathology to medial temporal lobe atrophy in Alzheimer's disease

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Robin de FloresDavid A Wolk
April 27, 2020

Estrogen receptor beta (ESR2) gene polymorphism and susceptibility to dementia

Acta neurologica Belgica
Zulvikar Syambani Ulhaq, Cristian Peinado Garcia
May 18, 2020

Baseline demographic, clinical, and cognitive characteristics of the Alzheimer's Prevention Initiative (API) Autosomal-Dominant Alzheimer's Disease Colombia Trial

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Silvia Rios-Romenetsand the API ADAD Colombia Trial Group
April 24, 2020

Association of traumatic brain injury with dementia and memory decline in older adults in the United States

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Leslie GrassetAdina Zeki Al Hazzouri
April 14, 2020
Open Access

Alzheimer's Disease and Alzheimer's Disease-Related Dementias in Older African American and White Veterans

Journal of Alzheimer's Disease : JAD
Yan ChengQing Zeng-Treitler
May 8, 2020

Armand W. Loranger (1930-2019)

The American Psychologist
Mark F Lenzenweger
April 14, 2020

Racial and Ethnic Differences in Knowledge About One's Dementia Status

Journal of the American Geriatrics Society
Pei-Jung LinKaren M Freund
April 15, 2020

Adherence to a Mediterranean diet and cognitive function in the Age-Related Eye Disease Studies 1 & 2

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Tiarnán D KeenanAREDS and AREDS2 Research Groups
April 21, 2020
Review

The impact of nutrition on COVID-19 susceptibility and long-term consequences

Brain, Behavior, and Immunity
Michael J Butler, Ruth M Barrientos

See more papers from this feed

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/cognitive-decline-environmental-and-genetic/15132ad7-f227-467e-9ad1-51ecbb3ee9e0